Esperion Therapeutics (NASDAQ:ESPR) reported its Q4 earnings results on Tuesday, February 22, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Esperion Therapeutics beat estimated earnings by 22.03%, reporting an EPS of $-1.77 versus an estimate of $-2.27.
Revenue was up $5.76 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.17 which was followed by a 3.3% increase in the share price the next day.
Here's a look at Esperion Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -2.79 | -1.84 | -2.52 | -3.76 |
| EPS Actual | -2.62 | -1.67 | -3.50 | -3.89 |
| Revenue Estimate | 12.85M | 42.27M | 26.12M | 12.52M |
| Revenue Actual | 14.41M | 40.66M | 7.98M | 9.64M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
